Literature DB >> 12663732

Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.

A Gronchi1, P G Casali, L Mariani, S Lo Vullo, M Colecchia, L Lozza, R Bertulli, M Fiore, P Olmi, M Santinami, J Rosai.   

Abstract

PURPOSE: To explore prognostic factors in surgically treated aggressive fibromatosis (extra-abdominal desmoid tumor). PATIENTS AND METHODS: A total of 203 consecutive patients treated with surgery over a 35-year period at a single referral center were retrospectively reviewed. One hundred twenty-eight were first seen at our institution with primary disease, whereas 75 had a recurrent tumor. All patients underwent macroscopically complete resection. Margins were rated as negative in 146 (97 with primary tumors, 49 with recurrences) and positive in 57 (31 in primary, 26 in recurrences) patients. Median follow-up was 135 months.
RESULTS: Patients with primary disease had a better disease-free survival rate than those with recurrence (76% v 59% at 10 years). Presenting with a recurrence was also the strongest predictor of local failure in the multivariate analysis. In patients first treated for primary disease, size and site had prognostic significance, whereas microscopically positive surgical margins did not. In contrast, in patients with recurrence, there was a trend toward better prognosis if margins were negative (although this was not significant at multivariate analysis).
CONCLUSION: Presence of microscopic disease does not necessarily affect long-term disease-free survival in patients with primary presentation of extra-abdominal desmoid tumors. Thus, function-sparing surgery may be a reasonable choice when feasible without leaving macroscopic residual disease. In patients with recurrences, positive margins may more clearly affect prognosis, potentially necessitating adjuvant radiation in selected cases.

Entities:  

Mesh:

Year:  2003        PMID: 12663732     DOI: 10.1200/JCO.2003.05.150

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  74 in total

1.  Recurrence patterns and management options in aggressive fibromatosis.

Authors:  Rajaraman Ramamurthy; Balasubramanian Arumugam; Balasubramaniam Ramanandham
Journal:  Indian J Surg Oncol       Date:  2012-05-12

2.  Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.

Authors:  Chuanxi Zheng; Jianguo Fang; Yitian Wang; Yong Zhou; Chongqi Tu; Li Min
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-15       Impact factor: 4.553

3.  [Aggressive fibromatosis in the jaw and facial region with bone involvement. A review].

Authors:  L Seper; P Hoppe; B Kruse-Lösler; A Büchter; U Joos; J Kleinheinz
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

4.  Postoperative radiotherapy in primary resectable desmoid tumors of the neck: a case-control study.

Authors:  Xiaoshuang Niu; Rui Jiang; Chaosu Hu
Journal:  Strahlenther Onkol       Date:  2019-06-06       Impact factor: 3.621

5.  Desmoid tumor of the facet joint: a case report.

Authors:  Han Ga Wi Nam; Seung-Myung Moon; Sei-Woong Jeon; Hyung Sik Hwang
Journal:  Korean J Spine       Date:  2013-06-30

Review 6.  A guide to oncological management of soft tissue tumours of the abdominal wall.

Authors:  K J Williams; A J Hayes
Journal:  Hernia       Date:  2013-09-17       Impact factor: 4.739

7.  Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis.

Authors:  Justin M M Cates
Journal:  Pathol Oncol Res       Date:  2015-04-29       Impact factor: 3.201

Review 8.  Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.

Authors:  Douglas S Hawkins; Sheri L Spunt; Stephen X Skapek
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

9.  Juvenile female with chest wall fibromatosis located posteriorly to the right breast: radiation therapy or wait and watch?

Authors:  Ali Akhavan; Fariba Binesh; Kargar Kargar; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2013-02-20

10.  MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours.

Authors:  Firouzeh Kamali; Wei-Lien Wang; B A Guadagnolo; Patricia S Fox; Valerae O Lewis; Alexander J Lazar; Anthony P Conley; Vinod Ravi; Mohammad Toliyat; Harshad S Ladha; Brian P Hobbs; Behrang Amini
Journal:  Br J Radiol       Date:  2015-11-18       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.